(Q48738118)

15 February 2018

title

A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients. (English)

1 reference

15 February 2018

main subject

major depressive episode

1 reference

1 reference

1 reference

Sechter D

1

1 reference

15 February 2018

Troy S

series ordinal

2

1 reference

15 February 2018

Paternetti S

series ordinal

3

1 reference

15 February 2018

Boyer P

series ordinal

4

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

15 February 2018

published in

European Psychiatry

1 reference

15 February 2018

volume

14

1 reference

15 February 2018

page(s)

41-48

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

The hospital anxiety and depression scale

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2980714-7

7 January 2021

Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2980714-7

7 January 2021

Depression: treatment compliance in general practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2980714-7

7 January 2021

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2980714-7

7 January 2021

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2980714-7

7 January 2021

Practice guideline for major depressive disorder in adults. American Psychiatric Association

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2980714-7

7 January 2021

Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2899%2980714-7

7 January 2021

10.1016/S0924-9338(99)80714-7

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

10572324

1 reference

15 February 2018